info@seagull-health.com
SeagullHealth
语言:
search
new
Indications for Siponimod (Mayzent)
516
Article source: Seagull Pharmacy
Oct 30, 2025

Siponimod (Mayzent) is a sphingosine 1-phosphate (S1P) receptor modulator used for the treatment of relapsing forms of multiple sclerosis (MS).

Indications for Siponimod (Mayzent)

Primary Indications

Siponimod is indicated for the treatment of adult patients with the following relapsing forms of multiple sclerosis (MS).

Clinically Isolated Syndrome (CIS): For patients who experience a first demyelinating event and are at high risk of relapse.

Relapsing-Remitting Multiple Sclerosis (RRMS): For reducing the frequency of disease relapses and delaying the progression of disability.

Active Secondary Progressive Multiple Sclerosis (aSPMS): For patients with secondary progressive disease who have evidence of disease activity (such as relapses or MRI lesions).

Dosage Forms, Strengths and Properties of Siponimod (Mayzent)

Dosage Forms and Strengths

0.25mg tablets: Light red, round, biconvex film-coated tablets with beveled edges. One side is engraved with "T", and the other side is blank.

1mg tablets: Purple-white, round, biconvex film-coated tablets with beveled edges. One side is engraved with "L", and the other side is blank.

2mg tablets: Light yellow, round, biconvex film-coated tablets with beveled edges. One side is engraved with "II", and the other side is blank.

Excipient Ingredients

The tablet core contains microcrystalline cellulose, crospovidone, etc.

The film coating contains polyvinyl alcohol, titanium dioxide, and iron oxide colorants (red and black iron oxides for 0.25mg and 1mg tablets; red and yellow iron oxides for 2mg tablets), etc.

Administration Method

Swallow the tablet whole. Do not split, crush, or chew it.

A 5-day dose escalation (starting at 0.25mg/day and gradually increasing to 2mg/day) is required to reduce the risk of cardiac adverse reactions.

Storage Methods for Siponimod (Mayzent)

Unopened Packaging

Store under refrigeration at 2°C–8°C (36°F–46°F).

After being dispensed to patients by the pharmacy, it can be stored at room temperature (20°C–25°C / 68°F–77°F) for a maximum of 3 months.

Opened Packaging

Bottled tablets: After opening, they can be stored at room temperature for 3 months, no refrigeration required.

Initiation pack (blister cards): After opening, the original calendarized blister packaging must be retained, and the product should be stored at room temperature for no more than 3 months.

Precautions

Avoid direct sunlight and humid environments.

Keep out of the reach of children.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
How to Purchase Siponimod (Mayzent)
Siponimod (Mayzent) is a sphingosine 1-phosphate (S1P) receptor modulator used for the treatment of relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relaps...
What Are the Side Effects of Fedratinib (Inrebic)?
Fedratinib (Inrebic) is a kinase inhibitor used for the treatment of adult patients with intermediate-2 or high-risk primary myelofibrosis (MF), or myelofibrosis secondary to polycythemia vera or esse...
Precautions for Fedratinib (Inrebic) Administration
Fedratinib (Inrebic) is a kinase inhibitor. It is indicated for the treatment of adult patients with intermediate-2 or high-risk primary myelofibrosis, or myelofibrosis secondary to polycythemia vera/...
How to Use Fedratinib (Inrebic)
Fedratinib (Inrebic) is a kinase inhibitor. It is indicated for the treatment of adult patients with intermediate-2 or high-risk primary myelofibrosis, or myelofibrosis secondary to polycythemia vera ...
How to Use Siponimod (Mayzent)
Siponimod (Mayzent) is a sphingosine 1-phosphate (S1P) receptor modulator used for the treatment of relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relaps...
Precautions for Administration of Isavuconazonium Sulfate Capsules (Cresemba)
Isavuconazonium Sulfate Capsules (Cresemba) are a triazole antifungal agent primarily indicated for the treatment of invasive aspergillosis and mucormycosis.Precautions for Administration of Isavucona...
How to Purchase Clofazimine
Clofazimine is a prescription medication used for the treatment of leprosy and certain mycobacterial infections. Due to its specific uses and pharmacological properties, its purchase must strictly com...
Indications for Clofazimine
Clofazimine is an antimycobacterial agent. Since its approval in the United States in 1986, it has been mainly used for the treatment of leprosy and its complications.Indications for ClofazimineTreatm...
Related Articles
Contraindications and adverse reactions of itraconazole
Although eltrombopag has no absolute contraindications, it has clear warnings and potential serious adverse reactions. Understanding these risks is a prerequisite for safe medication use.I. Contraindi...
Special population medication of eltrombopag
The use of eltrombopag in special populations requires individualized adjustment. This article reviews key medication points around factors such as hepatic and renal function, age, and ethnicity.I. Do...
Precautions for healthy diet of patients with eltrombopag
When taking eltrombopag, diet directly affects drug absorption and efficacy. Mastering the correct dietary principles is an important part of ensuring safe and effective treatment.I. Timing of Medicat...
Contraindications and adverse reactions of Epclusa
Epclusa is generally well tolerated, but contraindications and adverse reactions require special attention when combined with ribavirin. The following explains from three aspects.I. Contraindications1...
Special population use of Epclusa
Epclusa requires no dosage adjustment in most special populations, but some populations require careful evaluation. The following explains three situations separately.I. Populations with Abnormal Live...
Precautions for healthy diet of patients with Epclusa
During treatment with Epclusa, there are no special dietary restrictions, but a reasonable diet can help reduce discomfort and ensure efficacy. The following explains from three aspects.I. Administrat...
Contraindications and Adverse Reactions of Capmatinib
Capmatinib is used for metastatic non-small cell lung cancer with a mutation that leads to MET exon 14 skipping. It has no absolute contraindications, but several adverse reactions require close monit...
Dietary precautions for patients with Capmatinib
Capmatinib may be taken with or without food, but dietary components, dosing habits, and concomitant medications can directly affect efficacy and safety. The following explains administration, dietary...
New Drugs
Cenobamate(Xcopri)
Cenobamate(Xcopri)
It is used for the treatment of partial-onset seizures in adults (with or...
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved